Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP6 activates robust CXCL10. 1 / 1

| 1

➶

eidos

"It is highly likely that USP6 will be able to promote T cell recruitment and activation in vivo , given that USP6 induces robust production of CXCL10 , that CM from USP6-expressing ES cells can stimulate migration of primary T lymphocytes , and that ES cells expressing USP6 can induce APC activation in vivo ( as monitored by CD86 and MHCII surface upregulation ) ."

33558334

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...